Urgent.News

What's breaking now, across thousands of outlets.

Editions

Business

Brii Biosciences advances HBV study data alongside half year financial results

Biotechnology company Brii Biosciences released Phase 2b clinical data for its hepatitis B treatment strategy on 21 August 2026 alongside half year financial reporting

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Business

More from Friday 21 August →